Pacific Biosciences of California Inc (PACB):企業の財務・戦略的SWOT分析

◆英語タイトル:Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME45514FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Pacific Biosciences of California Inc (PACB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consumables. Its products enable the identification of novel genes; characterization of alternatively spliced isoforms in prominent gene families, and targeted sequencing, and provide real-time kinetic data for characterization of epigenomes. Pacific Biosciences’ products are based on its novel single molecule, real-time (SMRT) sequencing technology. It caters to scientific and research communities, government and commercial entities. The company has subsidiaries in the US, Canada, Germany, Japan, China, Singapore, and the UK. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc Key Recent Developments

Feb 10,2021: Pacific Biosciences of California announces fourth quarter and fiscal year 2020 financial results
Jan 28,2021: Pacific Biosciences of California Fourth Quarter 2020 Financial Results Call
Jan 13,2021: Pacific Biosciences and Invitae to develop ultra-high-throughput clinical whole genome sequencing platform
Jan 11,2021: Pacific Biosciences of California announces preliminary Fourth Quarter 2020 Revenue
Jan 08,2021: Pacific Biosciences announces appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Pacific Biosciences of California Inc – Key Facts
Pacific Biosciences of California Inc – Key Employees
Pacific Biosciences of California Inc – Key Employee Biographies
Pacific Biosciences of California Inc – Major Products and Services
Pacific Biosciences of California Inc – History
Pacific Biosciences of California Inc – Company Statement
Pacific Biosciences of California Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Pacific Biosciences of California Inc – Business Description
Business Segment: Product Revenue
Performance
Business Segment: Service and Other
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe (including the Middle East and Africa)
Performance
Geographical Segment: North America
Performance
R&D Overview
Pacific Biosciences of California Inc – Corporate Strategy
Pacific Biosciences of California Inc – SWOT Analysis
SWOT Analysis – Overview
Pacific Biosciences of California Inc – Strengths
Pacific Biosciences of California Inc – Weaknesses
Pacific Biosciences of California Inc – Opportunities
Pacific Biosciences of California Inc – Threats
Pacific Biosciences of California Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Pacific Biosciences of California Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Pacific Biosciences of California Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 10, 2021: Pacific Biosciences of California announces fourth quarter and fiscal year 2020 financial results
Jan 28, 2021: Pacific Biosciences of California Fourth Quarter 2020 Financial Results Call
Jan 13, 2021: Pacific Biosciences and Invitae to develop ultra-high-throughput clinical whole genome sequencing platform
Jan 11, 2021: Pacific Biosciences of California announces preliminary Fourth Quarter 2020 Revenue
Jan 08, 2021: Pacific Biosciences announces appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer
Nov 02, 2020: Pacific Biosciences of California announces third quarter 2020 financial results
Oct 22, 2020: Invitae and Pacific Biosciences collaborate to develop whole genome sequencing-based assays for pediatric epilepsy diagnostics
Oct 15, 2020: Children’s Mercy Kansas City teams up with Pacific Biosciences to fight rare disease
Oct 14, 2020: Pacific Biosciences of Californa announces the new President and Chief Executive Officer
Sep 14, 2020: Pacific Biosciences announces new Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Pacific Biosciences of California Inc, Key Facts
Pacific Biosciences of California Inc, Key Employees
Pacific Biosciences of California Inc, Key Employee Biographies
Pacific Biosciences of California Inc, Major Products and Services
Pacific Biosciences of California Inc, History
Pacific Biosciences of California Inc, Subsidiaries
Pacific Biosciences of California Inc, Key Competitors
Pacific Biosciences of California Inc, Ratios based on current share price
Pacific Biosciences of California Inc, Annual Ratios
Pacific Biosciences of California Inc, Annual Ratios (Cont...1)
Pacific Biosciences of California Inc, Interim Ratios
Pacific Biosciences of California Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Pacific Biosciences of California Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Pacific Biosciences of California Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Pacific Biosciences of California Inc (PACB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Institute on Drug Abuse:製薬・医療:M&Aディール及び事業提携情報
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Atkore International Group Inc. (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc. (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • International Flavors & Fragrances Inc.:企業の戦略・SWOT・財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CloudFlare Inc (NET):企業の財務・戦略的SWOT分析
    CloudFlare Inc (NET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • HCL Infosystems Limited:企業の戦略・SWOT・財務分析
    HCL Infosystems Limited - Strategy, SWOT and Corporate Finance Report Summary HCL Infosystems Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mycenax Biotech Inc (4726):製薬・医療:M&Aディール及び事業提携情報
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ecrins Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company provides products such as native and labeled tubulin, tubulin polymerization kit and monoclo …
  • Naturgy Energy Group SA:企業の戦略・SWOT・財務情報
    Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report Summary Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HSBC Trinkaus & Burkhardt Private Banking:企業の戦略・SWOT・財務情報
    HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSBC Trinkaus & Burkhardt Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CS Wind Corp (112610):企業の財務・戦略的SWOT分析
    Summary CS Wind Corp (CS Wind) formerly Choong San Corp, is a global wind tower company that manufactures and distributes aluminum platforms used for wind power generation towers. The company’s products include transition piece, wind tower, tower internal parts, oil and gas pipes, and plant equipmen …
  • Jabil Inc (JBL)-エネルギー分野:企業M&A・提携分析
    Summary Jabil Inc (Jabil) is a provider of electronic manufacturing services and solutions. It offers electronics design, production and product management services. Its service portfolio includes component selection, sourcing and procurement, integrated design and engineering, enclosure services an …
  • Liberty Mutual Holding Company Inc.:企業の戦略・SWOT・財務情報
    Liberty Mutual Holding Company Inc. - Strategy, SWOT and Corporate Finance Report Summary Liberty Mutual Holding Company Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MDNA Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Microgen plc (MCGN):企業の財務・戦略的SWOT分析
    Microgen plc (MCGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務情報
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆